Search Results - "Papi, Claudio"

Changes in Medical Management of Inflammatory Bowel Disease and Reducing Surgical Risk: Investigating Causality Through the Bradford-Hill Criteria.

Authors: Maggi, Daniela Papi, Claudio Festa, Stefano et al.

Source: Journal of Clinical Medicine. Jun2025, Vol. 14 Issue 11, p3824. 10p.

Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates.

Authors: Papi, Claudio Aratari, Annalisa Moretti, Alessandra et al.

Source: Digestive Diseases & Sciences. Jul2010, Vol. 55 Issue 7, p2002-2007. 6p. 1 Diagram, 2 Charts, 2 Graphs.

Long-Term Outcome of Crohn's Disease Following Corticosteroid-Induced Remission.

Authors: Papi, Claudio Festa, Virginia Leandro, Gioacchino et al.

Source: American Journal of Gastroenterology (Springer Nature). Apr2007, Vol. 102 Issue 4, p814-819. 6p. 2 Charts, 2 Graphs.

Management of Diverticular Disease: Is There Room for Rifaximin?

Authors: Papi, Claudio Koch, Maurizio Capurso, Lucio

Source: Chemotherapy (0009-3157). Apr2005 Supplement 1, Vol. 51 Issue S1, p110-114. 5p. 1 Chart, 1 Graph.

Timing of Cholecystectomy for Acute Calculous Cholecystitis: A Meta-Analysis.

Authors: Papi, Claudio Catarci, Marco D'Ambrosio, Letizia et al.

Source: American Journal of Gastroenterology (Springer Nature). Jan2004, Vol. 99 Issue 1, p147-155. 9p.

The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study.

Authors: Cantoro, Laura Di Sabatino, Antonio Papi, Claudio et al.

Source: Journal of Crohn's & Colitis. Aug2017, Vol. 11 Issue 8, p975-980. 6p.

Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study.

Authors: Aratari, Annalisa Scribano, Maria Lia Pugliese, Daniela et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2024, Vol. 59 Issue 12, p1579-1588. 10p.

Stricturing Crohn's disease: what is the role of endoscopic stenting? A systematic review.

Authors: Scotti, Giorgia Burrelli Lorenzetti, Roberto Aratari, Annalisa et al.

Source: Clinical Endoscopy. Nov2023, Vol. 56 Issue 6, p726-734. 9p.

Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies.

Authors: Pugliese, Daniela Onali, Sara Privitera, Giuseppe et al.

Source: Journal of Clinical Medicine. Nov2022, Vol. 11 Issue 22, p6717. 22p.

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus.

Authors: Daperno, Marco Armuzzi, Alessandro Danese, Silvio et al.

Source: Gastroenterology Research & Practice. 9/2/2019, p1-9. 9p.

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study.

Authors: Pugliese, Daniela Aratari, Annalisa Festa, Stefano et al.

Source: Gastroenterology Research & Practice. 10/3/2018, p1-7. 7p.

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.

Authors: Biancone, Livia Armuzzi, Alessandro Scribano, Maria Lia et al.

Source: Journal of Crohn's & Colitis. 8/1/2016, Vol. 10 Issue 8, p913-924. 12p.

Fecal Microbiota Transplantation for Recurrent C. difficile Infection in a Patient with Chronic Refractory Ulcerative Colitis.

Authors: Aratari, Annalisa Cammarota, Giovanni Papi, Claudio

Source: Journal of Crohn's & Colitis. Apr2015, Vol. 9 Issue 4, p367-367. 1p.

Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy.

Authors: Scribano, Maria Lia Aratari, Annalisa Neri, Benedetto et al.

Source: Therapeutic Advances in Gastroenterology. 2/14/2022, Vol. 15, p1-13. 13p.

Low Bioavailability and Traditional Systemic Steroids in IBD: Can the Former Take Over the Latter?

Authors: Fascì Spurio, Federica Aratari, Annalisa Margagnoni, Giovanna et al.

Source: Journal of Gastrointestinal & Liver Diseases. Mar2013, Vol. 22 Issue 1, p65-71. 7p. 1 Diagram, 3 Graphs.

Early Treatment in Crohn's Disease: Do We Have Enough Evidence to Reverse the Therapeutic Pyramid?

Authors: Spurio, Federica Fascì Aratari, Annalisa Margagnoni, Giovanna et al.

Source: Journal of Gastrointestinal & Liver Diseases. Mar2012, Vol. 21 Issue 1, p67-73. 7p.

The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.

Authors: Macaluso, Fabio Salvatore Caprioli, Flavio Benedan, Laura et al.

Source: Autoimmunity Reviews. May2024, Vol. 23 Issue 5, pN.PAG-N.PAG. 1p.

Magnetic resonance enterography in Crohn’s disease: new simple proposal to assess disease activity.

Authors: Iannicelli, Elsa Martini, Isabella Fantini, Claudia et al.

Source: Clinical Imaging. May/Jun2016, Vol. 40 Issue 3, p492-497. 6p.

Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.

Authors: Orlando, Ambrogio Mocciaro, Filippo Renna, Sara et al.

Source: Journal of Crohn's & Colitis. Oct2014, Vol. 8 Issue 10, p1217-1221. 5p.

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy.

Authors: Monterubbianesi, Rita Aratari, Annalisa Armuzzi, Alessandro et al.

Source: Journal of Crohn's & Colitis. Aug2014, Vol. 8 Issue 8, p852-858. 7p.